5 innovative ways to improve patient engagement in clinical trials
Abish Ghimire
Co-Founder of Ribera Solutions (AI consulting, Automation and Software Development)
What is Patient Engagement and why is it important?
The FDA defines patient engagement as “intentional, meaningful interactions with patients that provide opportunities for mutual learning, and effective collaborations.” The key words here are intentional and meaningful. Every small interaction must be designed with an intentional outcome, which allows an individual to interact and achieve the desired results. Although patient engagement has been acknowledged by the FDA as a key component for success of clinical trials, the industry still struggles to offer meaningful interactions with patients throughout the clinical trial journey. Other challenges such as patient recruitment, data management, and clinical operation processes take precedence over patient engagement, leaving patients’ needs unmet.
As much as digital interactions are important, proper bedside manner is equally important to create trusted relationships and a safe atmosphere for patients. Sponsors can benefit from taking a human-centered design approach, intentionally including engagement strategies throughout the patient trial journey. These interactions must be timely and meaningful so that they help patients achieve their milestones and feel appreciated for their efforts. A meaningful interaction often requires a clear understanding of participants' motivations, analysis of their behaviors, recognizing patterns, then forming an appropriate response. In the end, good engagement strategies will reduce the participants' burden and empower them with tools to complete the trial.
In this white paper we have introduced patient engagement and why it is important, and what happens when engagement is poor.
Oncology Pharma (OTC: ONPH) has published my white paper on "5 Innovative Ways to Improve Patient Engagement in Clinical Trials". Please read the full White Paper here
Abish, great article on the need for patient-centricity in the clinical trial industry. Congratulations!
Patient-Powered Health | Research | Advocacy | Engagement
1 年I really like the “high-tech with high-touch” term and definition - an interaction that combines the connection of real-world engagements with digital interfaces and workflows that make managing the trial experience more fluid and seamless.?This is so important for key stakeholders in the implementation of clinical research - participants, clinical site personnel, navigators, and caregivers. Developing the core elements of the platform may seem like a daunting task, but would result in much better attrition and adherence, as well as improved data robustness. #patientsaspartners #patientengagement
CEO | Tech Leader in AI, AWS, SaaS, DevOps, Kubernetes, Python, Serverless and Cloud-Native Development
3 年Great post, Abish
Technology Manager - Telecom Projects at Transport Sydney Trains
3 年Congratulations! Good and insightful article, which can have a positive impact on the clinical trials practices..
Advisory Board Member, Interim Chief Officer, & Strategic Program Director—Trained by Peter F. Drucker & Skilled in Boosting Revenues, Efficiencies, & Earnings in Impact-Accountable Social-Benefit Enterprises
3 年Kudos! Presuming you've spoken with Gerald Bruce about the health literacy, plain language, and cultural competence tie in c/o Nick Collatos. If not, let's chat ASAP.